Quarterly report pursuant to Section 13 or 15(d)

Net loss per share (Tables)

v3.22.1
Net loss per share (Tables)
3 Months Ended
Mar. 31, 2022
Net loss per share [Abstract]  
Anti-dilutive Securities Excluded from Computation of Net Loss per Share
The following potential common shares were not considered in the computation of diluted net loss per share as their effect would have been anti-dilutive for the three-month periods ended presented below:
 
   
March 31,
 
   
2022
   
2021
 
Series A, Series B and RDO warrants
   
7,282,999
     
7,374,172
 
Stock options
   
2,616,544
     
1,818,612
 
Unissued common stock for services
   
8,024
     
4,474
 
Former Rexahn warrants
   
66,538
     
66,538
 
Former Rexahn options
   
82
     
123